Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping. [PDF]
McCormack NM +5 more
europepmc +1 more source
Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model. [PDF]
Lin J +17 more
europepmc +1 more source
A Comprehensive Analysis of CSN1S2 I and II Transcripts Reveals Significant Genetic Diversity and Allele-Specific Exon Skipping in Ragusana and Amiatina Donkeys. [PDF]
Cosenza G, Pauciullo A.
europepmc +1 more source
Highly efficient CRISPR/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa. [PDF]
du Rand A +12 more
europepmc +1 more source
Twin Prime Editing Mediated Exon Skipping/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa. [PDF]
Steinbeck BJ +16 more
europepmc +1 more source
Cellular senescence induced by down-regulation of PTBP1 correlates with exon skipping of mitochondrial-related gene NDUFV3. [PDF]
Yang Y +6 more
europepmc +1 more source
Author Correction: Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. [PDF]
Galli F +18 more
europepmc +1 more source
Related searches:
Exon-skipping therapy for Duchenne muscular dystrophy
The Lancet, 2009Duchenne muscular dystrophy (DMD) is a lethal muscle disorder caused by mutations in the DMD gene for which no mutation‐targeted therapy has been available thus far. However, exon‐skipping mediated by antisense oligonucleotides (AOs), which are short single‐strand DNAs, has considerable potential for DMD therapy, and clinical trials in DMD patients are
Akinori, Nakamura, Shin'ichi, Takeda
openaire +3 more sources
DNA Diagnostics and Exon Skipping
2012The predominate form of DNA diagnostics remains nucleic acid sequencing in the research and clinical setting. While DNA sequencing allows a mutation to be correctly identified, only RNA sequencing can confirm the effect of that mutation on the resulting mRNA transcript.
Umasuthan, Srirangalingam, Shern L, Chew
openaire +2 more sources
Exon Skipping Mutations in Neurofibromatosis
2012Defects at the level of pre-mRNA splicing represent a common source of disease mutations in almost all known diseases with a genetic aetiology. In general, it is commonly accepted that 15% of all pathogenic mutations are caused by splicing defects. However, this is probably a conservative estimate since clinical practice has only recently begun to ...
Buratti, Emanuele, Baralle, Diana
openaire +3 more sources

